Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2010
10/14/2010WO2010117233A2 Stable pharmaceutical composition containing fluvastatin and method for manufacturing the same
10/14/2010WO2010117050A1 Solid preparation containing dibenz[b,e]oxepine derivative
10/14/2010WO2010117035A1 Complex and process for production thereof, and granules and tablets
10/14/2010WO2010116185A1 Insulin stabilized nanoparticles
10/14/2010WO2010116099A1 Method for preparing molecular complexes between adapalene and cyclodextrins
10/14/2010WO2010116098A1 Compositions comprising at least one complex composed of a derivative of naphthoic acid and of at least one cyclodextrin and uses thereof
10/14/2010WO2010116097A1 Method for preparing molecular complexes between a retinoid agent and cyclodextrins
10/14/2010WO2010115886A1 Active pharmaceutical ingredient adsorbed on solid support
10/14/2010WO2010115830A2 Pharmaceutical agent
10/14/2010WO2010115630A1 Amatoxin-armed target-binding moieties for the treatment of cancer
10/14/2010WO2010115629A2 Amatoxin-armed therapeutic cell surface binding components designed for tumour therapy
10/14/2010WO2010080618A3 Porous reactive frameworks
10/14/2010WO2010080580A3 Extended-release pharmaceutical formulations
10/14/2010WO2010075060A3 Methods and compositions for modulating proline levels
10/14/2010WO2010074541A3 Drug delivery carrier using zz domain
10/14/2010WO2010070300A3 Thiol-functionalising reagents and their uses
10/14/2010WO2010068705A3 Encapsulated agent guided imaging and therapies
10/14/2010WO2010063483A3 Active ingredient-peptide construct for extracellular enrichment
10/14/2010WO2010062570A3 COMPOSITIONS COMPRISING CAPTURE PEPTIDES FOR A β-AMYLOID PEPTIDE
10/14/2010WO2010042742A3 Chimeric therapeutics, compositions, and methods for using same
10/14/2010WO2009120182A3 Sulfo-polymer powder and sulfo-polymer powder blends with carriers and/or actives
10/14/2010WO2009102375A3 Use of avicins to deliver therapeutic and diagnostic agents
10/14/2010WO2009101518A3 Gellan gum based hydrogels for regenerative medicine and tissue engineering applications, its system, and processing devices
10/14/2010US20100262141 Surgical instrument for sealing blood vessels, and heat-curable adhesive as a medicament
10/14/2010US20100261946 Flexible and/or elastic brachytherapy seed or strand
10/14/2010US20100261885 PEGylation by the Dock and Lock (DNL) Technique
10/14/2010US20100261875 Peptides that specifically bind HGF receptor (CMET) and uses thereof
10/14/2010US20100261841 Intermediates Useful in the Preparation of Maleimide Functionalized Polymers
10/14/2010US20100261799 Stable and compatible polymer blends
10/14/2010US20100261748 Stable loratadine spill resistant formulation
10/14/2010US20100261746 Pharmaceutical formulation
10/14/2010US20100261745 Pharmaceutical formulation
10/14/2010US20100261744 Pharmaceutical formulation
10/14/2010US20100261672 Pharmaceutical compositions of pyrimidine-2,4,6-triones
10/14/2010US20100261670 Complexes of phosphate derivatives
10/14/2010US20100261273 Mammalian Receptor Proteins; Related Reagents and Methods
10/14/2010US20100261167 In vivo screen using chemical inducers of dimerization
10/14/2010US20100260854 Granulate for the formulation of orodispersible tablets
10/14/2010US20100260846 Particles for delivery of nucleic acids and related devices and methods
10/14/2010US20100260840 Orodispersible pharmaceutical composition of agomelatine
10/14/2010US20100260831 Non-pegylated liposomal doxorubicin triple combination therapy
10/14/2010US20100260802 RECOMBINANT LIPIDATED PsaA PROTEIN, METHODS OF PREPARATION AND USE
10/14/2010US20100260758 In vivo modulation of neuronal transport
10/14/2010US20100260696 Aqueous Compositions Containing Alkoxylated Phosphoric Acid Triesters
10/14/2010US20100260688 New Formulation and Use Thereof
10/14/2010US20100260683 Thermolabile liposome with controlled release temperature
10/14/2010US20100260672 Peptides that specifically bind hgf receptor (cmet) and uses thereof
10/14/2010CA2758201A1 Amatoxin-armed therapeutic cell surface binding components designed for tumour therapy
10/14/2010CA2758200A1 Nanoparticle formulations and uses thereof
10/14/2010CA2757988A1 Active pharmaceutical ingredient adsorbed on solid support
10/14/2010CA2757645A1 Methods and materials for delivering molecules
10/14/2010CA2757471A1 Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses
10/14/2010CA2756246A1 Amatoxin-armed target-binding moieties for the treatment of cancer
10/14/2010CA2755171A1 Compositions comprising at least one complex composed of a derivative of naphthoic acid and of at least one cyclodextrin and uses thereof
10/14/2010CA2754828A1 Method for preparing molecular complexes between adapalene and cyclodextrins
10/13/2010EP2239274A1 New methods for diagnosis and treatment of tumours
10/13/2010EP2239273A1 A pharmaceutical composition comprosing an immunoglobulin fc as a carrier
10/13/2010EP2238988A1 Conjugated prodrugs of cc-1065 analogs
10/13/2010EP2238985A1 High concentration antibody-containing liquid formulation
10/13/2010EP2238980A1 Aqueous compositions containing metronidazole
10/13/2010EP2238979A1 Active pharmaceutical ingredient adsorbed on solid support
10/13/2010EP2238978A1 Pharmaceutical compositions containing an inclusion complex formed by disulfiram and a cyclodextrin, which can be used in the treatment of alcohol and cocaine dependence
10/13/2010EP2238977A2 Skin cleaning products
10/13/2010EP2238975A1 Gastric retention controlled drug delivery system
10/13/2010EP2238973A1 Lyophilized preparations of proteasome inhibitors
10/13/2010EP2238843A1 Compositions of fat-soluble active ingredients containing protein-polysaccharide conjugates
10/13/2010EP2238251A1 Silencing of polo-like kinase expression using interfering rna
10/13/2010EP2238169A1 Method of decreasing cytotoxic side-effects and improving efficacy of immunoconjugates
10/13/2010EP2237772A2 Method and multilayered device for controlled topical delivery of therapeutic agents to the skin
10/13/2010EP1037642B9 Modified polysaccharides exhibiting altered biological recognition
10/13/2010CN1993131B Film-coated tablet
10/13/2010CN1976691B Cysteamines for treating complications of hypercholesterolemia and diabetes
10/13/2010CN1927202B Vitamin E nicotinate microcapsule and its preparing process
10/13/2010CN1867320B Monodispersed solid lipid particle compositions
10/13/2010CN1802171B Stable, aqueous solution of human erythropoietin, not containing serum albumin
10/13/2010CN101861187A Methods and compositions for treating dry eye
10/13/2010CN101861169A Stabilisation of oily suspensions containing hydrophobic silicic acids
10/13/2010CN101861148A Lidocaine tape preparation
10/13/2010CN101861142A Stabilisation of liquid-formulated factor VII(a) polypeptides by aldehyde-containing compounds
10/13/2010CN101861141A Rinse solution
10/13/2010CN101857698A Polystyrene/calcium alginate composite gel microsphere in nuclear shell structure and preparation method thereof
10/13/2010CN101857666A Cellulose ether grafted and modified temperature-sensitive hydrogel and preparation method thereof
10/13/2010CN101857647A Method for preparing floating konjac glucomannan (KGM) and application
10/13/2010CN101857615A Leucosceptoside B and preparation method and application thereof
10/13/2010CN101857614A Leucosceptoside A and preparation method and application thereof
10/13/2010CN101856500A Application of pharmaceutical excipient
10/13/2010CN101856499A Solution-aid system for insoluble medicinal injection and injection thereof
10/13/2010CN101856493A Compound piracetam brain protein hydrolysate tablet and preparation method thereof
10/13/2010CN101856444A Optimization of film coating technology of shenshuanning tablet
10/13/2010CN101856432A Preparation method of chitosan nanoparticles encapsulated tea polyphenol
10/13/2010CN101856396A Dispersible tablet for treating hepatitis B and preparation method thereof
10/13/2010CN101856389A Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases and application thereof
10/13/2010CN101856362A Pharmaceutical compositions for the treatment of asthma
10/13/2010CN101856359A Medicine compound against acute myeloid leukemia
10/13/2010CN101856354A Novel composition for reducing blood sugar
10/13/2010CN101856344A Patch and patch preparation
10/13/2010CN101856343A Patch and patch preparation
10/13/2010CN101856339A Controlled release dosage form and preparation method thereof
10/13/2010CN101856337A Novel penetration and controlled-release medicament delivery system and preparation method thereof
10/13/2010CN101856336A Mecobalamin sustained-release tablet and preparation method thereof
1 ... 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 ... 1712